Target intelligence / Profile preview

MicroRNA-203a-3p (miR-203a-3p)

Target
miR-203a-3p
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA-203a-3p is a single-stranded, non-coding RNA of 21–23 nucleotides that acts as a potent post-transcriptional regulator. In human cancer biology, it generally functions as a tumor suppressor: its expression is frequently downregulated in tumor tissues, and overexpression inhibits proliferation, migration, invasion, and promotes apoptosis in cancer cell lines. This molecule represses gene expression by binding to target mRNAs (such as thrombospondin 2, SLUG, MAP3K1, and PIK3CA), thus impacting critical cancer-related signaling pathways, including PI3K/Akt and Wnt. Its role is under active investigation for cancer diagnosis, prognosis, and therapy.

Other names
miR-203a-3pMIR203A (precursor gene)hsa-miR-203a-3p (human homolog; hsa=Homo sapiens)microRNA-203MIR203
02

Mechanism of action

Therapeutic use of *miR-203a-3p mimics* restores or increases miR-203a-3p levels to repress oncogenic targets such as THBS2, SLUG, MAP3K1, and PIK3CA. Anti-miR oligonucleotides may inhibit endogenous miR-203a-3p in conditions where its function is abnormal.

03

Biological functions

Cell cycle regulationApoptosisCell proliferationCell migration and invasionEpithelial–mesenchymal transition (EMT)AutophagyPost-transcriptional regulation of gene expression
04

Disease associations

Cancer, including colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, thyroid papillary carcinomaTumor suppressionMetastasis and lymphovascular invasion
05

Safety considerations

Off-target effects due to widespread gene regulation by miRNAsDelivery system toxicityImmunogenicity for miRNA-based therapiesUnintended systemic effects due to regulation of multiple pathways and genes
06

Biomarkers

Downregulation of miR-203a-3p expression has been associated with poor prognosis in several cancers and is under investigation as a diagnostic and prognostic biomarker, especially for cancer progression and lymphovascular invasion

Beyond the preview

Go deeper on MicroRNA-203a-3p (miR-203a-3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-203a-3p (miR-203a-3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call